SPC-GANIRELIX DIN 02569353
Status: Approved
Holder: SUN PHARMA CANADA INC
Health Canada record
| Active ingredient(s) | GANIRELIX (GANIRELIX ACETATE) 250 MCG |
|---|
| Dosage form | Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Human |
|---|
| ATC | H01CC01 GANIRELIX |
|---|
| Original market date | |
|---|
| Current status date | 22-Jun-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Sun Pharma Canada Inc. — licence 3-002572, currently licensed, last inspection rating C (2026-06-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GANIRELIX (GANIRELIX ACETATE)
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02245641 | ORGALUTRAN | ORGANON CANADA INC. | Solution | GANIRELIX (GANIRELIX ACETATE) 250 MCG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 37748 | 2026-06-22 | Abbreviated New Drug Submission (ANDS) | |
Request a quote for SPC-GANIRELIX
How to read a Canadian DIN record